Abstract

Abstract Preclinical safety studies of human subjects are an essential step in the drug development process. These studies provide valuable information for the investigational new drug (IND) application and the investigational drug brochure. This article focuses on the main issues related to preclinical studies of safety in human subjects.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call